NCT06860438

Brief Summary

In this thesis we will use the current state of knowledge that PI can provide a reliable information about the state of peripheral microcirculation during the state of sepsis and septic shock in ICU patients and that can interfere with the timing of starting vasopressor treatment in sepsis and septic shock

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2024

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

February 17, 2025

Completed
12 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 6, 2025

Completed
Last Updated

March 6, 2025

Status Verified

February 1, 2025

Enrollment Period

7 months

First QC Date

February 17, 2025

Last Update Submit

March 3, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • PI (perfusion index ) variable will be measured at the start of resuscitation and at the start of vasopressor therapy

    PI will be measured at the start of resuscitation after volume resuscitation and before the use of vasopressor then will be measured 6 hours after resuscitation

    PI variable will be recorded at baseline( T0 )and after 5 minutes from starting of resuscitation (T5) and then 6 hours thereafter for 24 hours

Secondary Outcomes (8)

  • Mean arterial Blood pressure

    Baseline (T0 ) ,5 miutes after initial fluid resuscitation (T5) and 6 hours thereafter (T6) for 24 hours

  • Heart rate (HR)

    Baseline (T0 ) ,5 miutes after initial fluid resuscitation (T5) and 6 hours thereafter (T6) for 24 hours

  • The central venous-arterial blood carbon dioxide partial pressure difference (Pv-aCO2)

    Baseline (T0 ) ,5 minutes after initial fluid resuscitation (T5) and 6 hours thereafter (T6) for 24 hours

  • arterial lactate concentration

    Baseline (T0 ) ,5 minutes after initial fluid resuscitation (T5) and 6 hours thereafter (T6) for 24 hours

  • ScvO2 (central venous oxygen saturation )

    Baseline (T0 ) ,5 minutes after initial fluid resuscitation (T5) and 6 hours thereafter (T6) for 24 hours

  • +3 more secondary outcomes

Study Arms (2)

vasopressor

Drug: Vasoconstrictor Agents

no vasopressor

Interventions

vasopressor agents will be started in patients with sepsis who will not improved using the resuscitation fluids

vasopressor

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

ICU patients with sepsis

You may qualify if:

  • \- All ICU patients with clinically suspected sepsis and septic shock ( signs include fever hypotension oliguria and confusion combined with culture results showing infection .Septic shock is a subset of sepsis involves persistent hypotension (mean arterial pressure ≥ 65 mm Hg, and a serum lactate level \> 18 mg/dL \[2 mmol/L)not responding to fluid resuscitation ) .

You may not qualify if:

  • Pregnant females
  • Patients on vasopressor or positive inotropic drugs
  • Patients with hypothermia (defined as central temperature \<35°C).
  • Patient with impairment of upper extremity circulation,(such as those who underwent radial artery harvesting for coronary artery bypass grafting or had suspected occlusion of the radial artery prior to surgery,)
  • Patients had undergone an operation that involved the large arteries of the aortic arch.
  • Patients with atherosclerosis .

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

faculty of medicine Ain Shams University

Cairo, 11757, Egypt

RECRUITING

MeSH Terms

Conditions

Sepsis

Interventions

Vasoconstrictor Agents

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Cardiovascular AgentsTherapeutic UsesPharmacologic ActionsChemical Actions and Uses

Study Officials

  • Nancy shaker ass,lecurer

    faculty of medicine, Ain Shams University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nancy Shaker ass.lecturer

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant lecturer of anesthesia

Study Record Dates

First Submitted

February 17, 2025

First Posted

March 6, 2025

Study Start

August 1, 2024

Primary Completion

March 1, 2025

Study Completion

March 1, 2025

Last Updated

March 6, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations